Vice President, Life Science
COTA- Full Time
- Senior (5 to 8 years)
Employment Type: Full-time
Tempus is seeking a passionate and experienced Account Vice President (Account VP) to join our Life Sciences team. Reporting directly to the SVP, Sales, Life Sciences, this role is responsible for managing the business relationship between Tempus and one of our largest biopharma strategic partners. The Account VP will lead a dedicated team focused on sales, delivery, execution, revenue recognition, and achieving key business performance indicators (KPIs). As the executive owner of the account, you will develop and implement strategies to ensure Tempus delivers significant value to the partner organization, driving long-term growth and collaboration. You will also guide a Key Account Director (KAD) and Project Manager focused on sales expansion and project execution within the account. The primary focus of this role is high-level account management, including strategy, scientific collaboration, and partnership development.
Tempus is a technology company focused on precision medicine. Our proprietary platform connects an entire ecosystem of real-world evidence to deliver real-time, actionable insights to physicians, providing critical information about the right treatments for the right patients, at the right time. We are passionate about advancing the healthcare industry through AI and meaningful impact in clinical care.
AI-driven healthcare data analysis platform
Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in healthcare. The company offers a platform that analyzes medical data to provide insights for physicians, helping them make better treatment decisions. This platform also aids pharmaceutical and biotech companies in drug development by identifying new targets and assessing treatment effectiveness. For patients, Tempus identifies personalized therapy options, particularly in cancer care, where their research has shown increased opportunities for tailored treatments. They have developed a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. Tempus generates revenue by charging healthcare providers and companies for access to their platform and insights, setting them apart from competitors by their focus on personalized medicine and extensive cancer research.